Schwartz EL - Search Results

1

Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.

Sparano JA, Schwartz EL, Salva KM, Pizzillo MF, Wadler S, Wiernik PH. Sparano JA, et al. Among authors: schwartz el. Am J Clin Oncol. 1990 Oct;13(5):374-8. doi: 10.1097/00000421-199010000-00002. Am J Clin Oncol. 1990. PMID: 2220657

2

Principles in the biomodulation of cytotoxic drugs by interferons.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Semin Oncol. 1992 Apr;19(2 Suppl 3):45-8. Semin Oncol. 1992. PMID: 1373005 Review.

3

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells.

Schwartz EL, Hoffman M, O'Connor CJ, Wadler S. Schwartz EL, et al. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1232-9. doi: 10.1016/0006-291x(92)91863-l. Biochem Biophys Res Commun. 1992. PMID: 1540167

4

Taxol: a new agent active in melanoma and ovarian cancer.

Einzig AI, Wiernik PH, Schwartz EL. Einzig AI, et al. Among authors: schwartz el. Cancer Treat Res. 1991;58:89-100. doi: 10.1007/978-1-4615-3876-9_5. Cancer Treat Res. 1991. PMID: 1683787 Review. No abstract available.

5

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Jun 15;50(12):3473-86. Cancer Res. 1990. PMID: 1692761 Review.

6

Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.

Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Sep 15;50(18):5735-9. Cancer Res. 1990. PMID: 1697499

7

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH. Wadler S, et al. Among authors: schwartz el. J Clin Oncol. 1989 Dec;7(12):1769-75. doi: 10.1200/JCO.1989.7.12.1769. J Clin Oncol. 1989. PMID: 2585018

8

Phase I clinical and pharmacokinetic study of taxol.

Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E. Wiernik PH, et al. Among authors: schwartz el. Cancer Res. 1987 May 1;47(9):2486-93. Cancer Res. 1987. PMID: 2882837

9

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

Wiernik PH, Schwartz EL, Einzig A, Strauman JJ, Lipton RB, Dutcher JP. Wiernik PH, et al. Among authors: schwartz el. J Clin Oncol. 1987 Aug;5(8):1232-9. doi: 10.1200/JCO.1987.5.8.1232. J Clin Oncol. 1987. PMID: 2887641

10

Differentiation of leukemia cells by chemotherapeutic agents.

Schwartz EL, Wiernik PH. Schwartz EL, et al. J Clin Pharmacol. 1988 Sep;28(9):779-94. doi: 10.1002/j.1552-4604.1988.tb03217.x. J Clin Pharmacol. 1988. PMID: 3068259 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters